2014
Serial Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Kelada O, Decker R, Zheng M, Huang Y, Xia Y, Gallezot J, Liu C, Rockwell S, Carson R, Oelfke U, Carlson D. Serial Imaging of Tumor Hypoxia in Early Stage Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s26-s27. DOI: 10.1016/j.ijrobp.2014.05.126.Peer-Reviewed Original ResearchWE‐G‐BRD‐06: Variation in Dynamic Positron Emission Tomography Imaging of Tumor Hypoxia in Early Stage Non‐Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Kelada O, Decker R, Zheng M, Huang Y, Xia Y, Gallezot J, Liu C, Rockwell S, Carson R, Oelfke U, Carlson D. WE‐G‐BRD‐06: Variation in Dynamic Positron Emission Tomography Imaging of Tumor Hypoxia in Early Stage Non‐Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy. Medical Physics 2014, 41: 520-520. DOI: 10.1118/1.4889490.Peer-Reviewed Original ResearchNon-small cell lung cancer patientsCell lung cancer patientsPositron emission tomographyTumor hypoxic volumeLung cancer patientsCancer patientsHypoxic volumeEarly stage non-small cell lung cancer patientsTumor hypoxiaTumor vascular responseStereotactic body radiotherapyTotal tumor volumeNovel pilot studyEmission Tomography ImagingPositron emission tomography (PET) imagingDifferent time pointsTreatment failureFirst patientVascular responsesBody radiotherapyNSCLC tumorsTreatment individualizationBlood ratioTumor volumeSingle patientMolecular Imaging of Tumor Hypoxia with Positron Emission Tomography
Kelada OJ, Carlson DJ. Molecular Imaging of Tumor Hypoxia with Positron Emission Tomography. Radiation Research 2014, 181: 335-349. PMID: 24673257, PMCID: PMC5555673, DOI: 10.1667/rr13590.1.Peer-Reviewed Original ResearchConceptsTumor hypoxiaOncology communityTumor hypoxic volumeImportant prognostic factorOverall treatment responseRisk of metastasisTypes of tumorsEmission Tomography ImagingPositron emission tomography (PET) imagingClinical oncology communityPositron emission tomographyConventional cancer therapiesMagnitude of hypoxiaPrognostic factorsCancer patientsTreatment responseField of PETChemotherapy resistanceEmission tomographyClinical settingRadiolabelled agentsCancer typesPatientsHypoxia tracerHypoxia
2008
SU‐GG‐T‐509: Impact of Gating On Dose Escalation in Lung Cancer Patients
Antony J, Loo B, Carlson D, Maxim P, Luxton G, Xing L. SU‐GG‐T‐509: Impact of Gating On Dose Escalation in Lung Cancer Patients. Medical Physics 2008, 35: 2842-2842. DOI: 10.1118/1.2962258.Peer-Reviewed Original ResearchNormal tissue complication probabilityDose escalationTumor marginsInferior tumor marginMean lung doseLocal tumor controlLung cancer patientsTreatment planningConformal radiation therapyTumor motionTumor control probability modelCRT plansLeft lungMediastinal tumorLung doseTumor controlCancer patientsToxicity CriteriaLung tumorsRadiation therapyDose changesLyman-KutcherBurman modelDose constraintsPatients